Provided by Tiger Trade Technology Pte. Ltd.

Regeneron Pharmaceuticals

823.82
+24.743.10%
Post-market: 823.880.0600+0.01%18:06 EDT
Volume:682.64K
Turnover:558.89M
Market Cap:84.82B
PE:20.37
High:824.63
Open:808.86
Low:804.32
Close:799.08
52wk High:847.00
52wk Low:541.00
Shares:102.95M
Float Shares:98.88M
Volume Ratio:1.05
T/O Rate:0.69%
Dividend:3.64
Dividend Rate:0.44%
EPS(TTM):40.43
EPS(LYR):41.48
ROE:14.04%
ROA:6.53%
PB:2.67
PE(LYR):19.86

Loading ...

The Scientist with 1,000 Patents Fueling a Drug Powerhouse

Dow Jones
·
Jul 25

Earning Preview: Regeneron Pharmaceuticals—this quarter’s revenue is expected to increase by 16.16%, and institutional views are predominantly bullish

Earnings Agent
·
Jul 24

Regeneron Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Jul 23

Movement Alert|Regeneron Pharmaceuticals Falls 3.28% in Regular Trading, Multiple Investment Banks Cut Target Prices Amid Earnings Warning

Market Focus
·
Jul 23

What Bundibugyo Ebola Vaccines and Treatments are Under Development

Reuters
·
Jul 22

Regeneron (REGN) Receives a Buy from Goldman Sachs

TIPRANKS
·
Jul 22

Analysts Are Bullish on These Healthcare Stocks: Valneva (VALN), Regeneron (REGN)

TIPRANKS
·
Jul 22

Regeneron’s POTS Study Wraps Up: What REGN7544 Could Mean for REGN Investors

TIPRANKS
·
Jul 22

Cantor Fitzgerald Adjusts Price Target on Regeneron Pharmaceuticals to $750 From $785

MT Newswires Live
·
Jul 22

Regeneron Pharma is Maintained at Buy by Guggenheim

Dow Jones
·
Jul 21

Telix Expects Fy2026 Revenue and Other Income Above US$1 Billion, Tracks Upper End of Guidance Range

Reuters
·
Jul 21

Goldman Sachs Adjusts Price Target on Regeneron Pharmaceuticals to $965 From $968, Maintains Buy Rating

MT Newswires Live
·
Jul 20

Biohaven enters into clinical supply agreement with Regeneron

TIPRANKS
·
Jul 20

Biohaven Signs Regeneron Supply Deal to Test Bhv-1530 with Libtayo

Reuters
·
Jul 20

Merck Gets US FDA Nod for First-in-its-class Oral Cholesterol Drug

Reuters
·
Jul 16

Movement Alert|Regeneron Pharmaceuticals Falls 3.2% in Pre-Market Trading, Multiple Banks Cut Target Prices Amid Q2 Earnings Warning

Market Focus
·
Jul 16

Booking, Alphabet, and 7 Other Stocks to Buy Ahead of Earnings

Dow Jones
·
Jul 16

Regeneron’s dupilumab granted orphan drug designation

TIPRANKS
·
Jul 15

Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Jul 15

These Biggest and "Least Loved" Stocks Are the Ones to Pick Ahead of Earnings

Dow Jones
·
Jul 13